Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Nov 20;9(91):36252-36253.
doi: 10.18632/oncotarget.26363.

DNA damage repair defects as a new class of endocrine treatment resistance driver

Meenakshi Anurag  1 , Matthew J Ellis  1 , Svasti Haricharan  1
Affiliations
Editorial

DNA damage repair defects as a new class of endocrine treatment resistance driver

Meenakshi Anurag et al. Oncotarget. .
No abstract available

Keywords: DNA repair; endocrine treatment resistance.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow chart depicting the number of predicted endocrine treatment resistant patients in the USA, and attributing known mechanisms of resistance based on estimated frequencies reported in the literature
Where evidence exists, putative diagnosis and therapeutic strategies to target each mechanism is included.
See this image and copyright information in PMC

References

    1. Ripperger T, et al. Eur J Hum Genet. 2009;17:722–31. https://doi.org/10.1038/ejhg.2008.212 - DOI - PMC - PubMed
    1. King MC, et al. Science. 2003;302:643–6. https://doi.org/10.1126/science.1088759 - DOI - PubMed
    1. Bryant HE, et al. Nature. 2005;434:913–7. https://doi.org/10.1038/nature03443 - DOI - PubMed
    1. Ballinger TJ, et al. Front Oncol. 2018;8:308. https://doi.org/10.3389/fonc.2018.00308 - DOI - PMC - PubMed
    1. Lei JT, et al. Cell Rep. 2018;24:1434–44.e7. https://doi.org/10.1016/j.celrep.2018.07.009 - DOI - PMC - PubMed

Publication types

LinkOut - more resources